HIV: open trials in Mozambique

• NCT07312266

  Questioning the Epidemiology of Asymptomatic TB

  Research · Barcelona Institute for Global Health

  Centro de Investigação em Saúde de Manhiça (CISM), Manhiça

  Registry updated 2025-12-31

• NCT05590455

  Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

  Trial Treatment · Phase 2 · ANRS, Emerging Infectious Diseases

  Instituto Nacional de Saude, Maputo

  Registry updated 2025-12-15

• NCT06747507

  Ndovu RCT: Investing the Optimal Management of Dolutegravir Resistance

  Trial Treatment · Phase 3 · University of Nairobi

  CS Ponta Gea, Beira · CS Machava II, Maputo · CS Ndlavela, Maputo

  Registry updated 2025-09-11

• NCT05580666

  Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)

  Trial Treatment · Phase 3 · Population Health Research Institute

  Faculty of Medicine, Eduardo Mondlane University, Maputo

  Registry updated 2025-09-03

• NCT06607588

  Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

  Research · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

  Hospital Carmelo, Chokwé

  Registry updated 2025-05-15

• NCT06267508

  Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment

  Research · Michael Hoelscher

  Centro de Investigacao Operacional de Beira (CIOB), Instituto Nacional de Saúde (INS), Ministério da Saúde,, Beira

  Registry updated 2024-11-18

• NCT06326294

  Assessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique

  Trial Treatment · Instituto Nacional de Saúde, Mozambique

  INSMozambique, Maputo

  Registry updated 2024-05-22

All HIV trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error